Literature DB >> 3444369

The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.

R W Wilcox1, R L Wykle, J D Schmitt, L W Daniel.   

Abstract

1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3) is an ether-linked lipid that exhibits selective cytotoxicity toward several types of tumor cells and is relatively inactive toward normal cells under the same conditions of treatment. The mechanis of this selective cytotoxicity is unknown. We conducted studies to determine whether this compound is metabolized by phospholipases C and D and, if so, whether sensitive and resistant cells differ in their ability to degrade ET-18-OCH3 by these enzymes. We have examined the metabolism of the L-isomer of ET-18-OCH3, 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine (L-ET-18-OCH3), by lysophospholipase D of rat liver microsomes and by a phospholipase D from the marine bacterium Vibrio damsela. The metabolism of L-ET-18-OCH3 was also examined in cell culture using Madin-Darby canine kidney cells, human promyelocytic leukemia cells and human myelocytic leukemia cells. In these studies, L-ET-18-OCH3 and related 1-O-alkyl-linked phosphocholine analogs radiolabeled with 3H in the 1-O-alkyl chain were used. L-ET-18-OCH3 was not hydrolyzed by lysophospholipase D from rat liver microsomes under conditions where cleavage of 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine was observed. However, phospholipase D from the marine bacterium V. damsela readily hydrolyzed L-ET-18-OCH3 to 1-O-[3H]octadecyl-2-O-methyl-sn-glycero-3-phosphate, demonstrating that L-ET-18-OCH3 can be degraded by a phospholipase D. Platelet-activating factor (PAF) and lyso-PAF were also substrates for the bacterial phospholipase D.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3444369     DOI: 10.1007/BF02535534

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  17 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  The biocleavage of alkyl glyceryl ethers in Morris hepatomas and other transplantable neoplasms.

Authors:  J F Soodsma; C Piantadosi; F Snyder
Journal:  Cancer Res       Date:  1970-02       Impact factor: 12.701

3.  Studies of lysophospholipase D of rat liver and other tissues.

Authors:  R L Wykle; W F Kraemer; J M Schremmer
Journal:  Arch Biochem Biophys       Date:  1977-11       Impact factor: 4.013

4.  Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.

Authors:  C I Hong; S H An; D J Buchheit; A Nechaev; A J Kirisits; C R West; W E Berdel
Journal:  J Med Chem       Date:  1986-10       Impact factor: 7.446

5.  Tumor promoter stimulation of phosphatidylcholine turnover in HeLa cells.

Authors:  G R Guy; A W Murray
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

6.  Purification and characterization of an extracellular cytolysin produced by Vibrio damsela.

Authors:  M H Kothary; A S Kreger
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

7.  Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells.

Authors:  W E Berdel; E Greiner; U Fink; D Stavrou; A Reichert; J Rastetter; D R Hoffman; F Snyder
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

8.  Identification of neutral active phospholipase C which hydrolyzes choline glycerophospholipids and plasmalogen selective phospholipase A2 in canine myocardium.

Authors:  R A Wolf; R W Gross
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

9.  Specificity of lysophospholipase D.

Authors:  R L Wykle; W F Kraemer; J M Schremmer
Journal:  Biochim Biophys Acta       Date:  1980-07-14

10.  Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.

Authors:  D R Hoffman; L H Hoffman; F Snyder
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

View more
  6 in total

1.  Activation of the epidermal platelet-activating factor receptor results in ICAM-1 expression.

Authors:  Y Pei; L C Dy; S Natarajan; J B Travers
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-01       Impact factor: 2.416

2.  Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.

Authors:  G W Small; J C Strum; L W Daniel
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

3.  Synthesis and biological evaluation of ether-linked derivatives of phosphatidylinositol.

Authors:  K S Ishaq; M Capobianco; C Piantadosi; A Noseda; L W Daniel; E J Modest
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

4.  Relationship of cell survival, drug dose, and drug uptake after 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine treatment.

Authors:  K Fujiwara; L W Daniel; E J Modest; C A Wallen
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Is metabolism an important arbiter of anticancer activity of ether lipids? Metabolism of SRI 62-834 and hexadecylphosphocholine by [31P]-NMR spectroscopy and comparison of their cytotoxicities with those of their metabolites.

Authors:  F E Bishop; C Dive; S Freeman; A Gescher
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Inhibition of proliferation and induction of differentiation of human and mouse myeloid leukemia cells by new ethyleneglycol-type nonphosphorus alkyl ether lipids.

Authors:  T Kasukabe; Y Honma; M Hozumi; H Nomura
Journal:  Jpn J Cancer Res       Date:  1990-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.